BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 10875917)

  • 1. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
    Chan FK; Chun HJ; Zheng L; Siegel RM; Bui KL; Lenardo MJ
    Science; 2000 Jun; 288(5475):2351-4. PubMed ID: 10875917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors.
    Deng GM; Zheng L; Chan FK; Lenardo M
    Nat Med; 2005 Oct; 11(10):1066-72. PubMed ID: 16170321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death.
    Sedger LM; Osvath SR; Xu XM; Li G; Chan FK; Barrett JW; McFadden G
    J Virol; 2006 Sep; 80(18):9300-9. PubMed ID: 16940541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.
    Hildt E; Oess S
    J Exp Med; 1999 Jun; 189(11):1707-14. PubMed ID: 10359574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1.
    Telliez JB; Xu GY; Woronicz JD; Hsu S; Wu JL; Lin L; Sukits SF; Powers R; Lin LL
    J Mol Biol; 2000 Jul; 300(5):1323-33. PubMed ID: 10903872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.
    Jiang Y; Woronicz JD; Liu W; Goeddel DV
    Science; 1999 Jan; 283(5401):543-6. PubMed ID: 9915703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of the p55 TNF receptor death domain and its lymphoproliferation mutants.
    De Wilde G; Murray-Rust J; Boone E; Olerenshaw D; McDonald NQ; Ibanez C; Haegeman G; Wollmer A; Federwisch M
    Eur J Biochem; 2001 Mar; 268(5):1382-91. PubMed ID: 11231290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.
    Gruss HJ; Dower SK
    Blood; 1995 Jun; 85(12):3378-404. PubMed ID: 7780126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
    Kajiwara K; Saito A; Ogata S; Tanihara M
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.
    Su Z; Wu Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
    Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
    J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.
    Chan FK
    Cytokine; 2007 Feb; 37(2):101-7. PubMed ID: 17449269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.
    Chan FK
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i50-3. PubMed ID: 11053089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
    Liu LS; Spelleken M; Röhrig K; Hauner H; Eckel J
    Diabetes; 1998 Apr; 47(4):515-22. PubMed ID: 9568681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for the cytotoxic ligand TRAIL.
    Pan G; O'Rourke K; Chinnaiyan AM; Gentz R; Ebner R; Ni J; Dixit VM
    Science; 1997 Apr; 276(5309):111-3. PubMed ID: 9082980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
    Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
    J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
    Gruss HJ; Duyster J; Herrmann F
    Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling.
    Ozsoy HZ; Sivasubramanian N; Wieder ED; Pedersen S; Mann DL
    J Biol Chem; 2008 Aug; 283(34):23419-28. PubMed ID: 18544535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.